[144] Vistra Corp. SEC Filing

Rhea-AI Filing Summary

Form 144 filed for Vistra Corp. (VST) shows a proposed sale of 19,605 common shares through Fidelity Brokerage Services with an aggregate market value of $3,818,705.55. The shares are reported as acquired via an option granted on 04/09/2018 with an acquisition date listed as 10/01/2025, and the planned sale date is 10/01/2025. The filing also discloses multiple recent open-market sales by the same person in September 2025 totaling 338,669 common shares with gross proceeds shown for each trade. The filing includes the required attestation that the seller is not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider disposition of a small equity stake; prior near-term sales were modest in aggregate versus outstanding shares.

The filing documents a proposed sale of 19,605 shares valued at $3.82 million, originating from options granted in 2018. Recent sales by the same holder in September 2025 total approximately 338,669 shares. Relative to the issuer's stated outstanding shares (338,820,324), these transactions represent only a trace percentage of the float, suggesting limited direct impact on capitalization or control. The disclosure meets Rule 144 notice requirements and contains the standard representation regarding material non-public information.

Corporate Governance Expert

TL;DR: Compliance-focused filing showing insider sales under Rule 144; no governance red flags evident from provided details.

The Form 144 identifies the nature of acquisition (option grant) and that payment will be in cash. The seller affirms no undisclosed material adverse information. There is no indication in this filing of unusual trading patterns beyond repeated small sales in September 2025 and the planned October sale. From a governance perspective, the filing appears to be a standard, compliant disclosure of intended sales by an insider or related person.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	19605	3818705.55	338820324	10/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2025	Option Granted - 04/09/2018	Issuer			19605	10/01/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/10/2025	19592	3933635.75
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/11/2025	43074	8991625.77
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/12/2025	21374	4335603.72
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/15/2025	21362	4481773.62
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/16/2025	21358	4565882.26
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/17/2025	21361	4540506.03
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/18/2025	21366	4554708.26
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/19/2025	21360	4517570.62
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/22/2025	21362	4503715.06
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/23/2025	21360	4490151.57
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/24/2025	21371	4355909.13
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/25/2025	21379	4273632.11
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/26/2025	21376	4300490.42
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/29/2025	21378	4316995.04
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/30/2025	19596	3905511.14

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Vistra Corp. (VST) disclose?

The filing discloses a proposed sale of 19,605 common shares valued at $3,818,705.55, acquired via option and planned for sale on 10/01/2025.

How were the 19,605 Vistra shares acquired?

The shares are reported as resulting from an option granted on 04/09/2018, with the acquisition date listed as 10/01/2025.

Were there prior sales by the same person before this Form 144?

Yes. The filing lists multiple open-market sales in September 2025 totaling approximately 338,669 common shares with stated gross proceeds for each trade.

What is the size of the planned sale relative to outstanding shares?

The proposed 19,605-share sale is a very small fraction of the reported 338,820,324 outstanding shares, representing a negligible percentage of the total.

Does the filer assert possession of undisclosed material information?

No. The filer signs the standard attestation stating they do not know any material adverse information not publicly disclosed.